First Page | Document Content | |
---|---|---|
Date: 2016-01-11 11:16:23Business Biotechnology Economy Pharmacy Pharmaceutical industry Pharmaceuticals policy Biopharmaceutical Pharmaceutical industry in India Novartis Biosimilar Boehringer Ingelheim Teva Pharmaceutical Industries | January 8, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion ImmunoOncology Deal In yetAdd to Reading ListSource URL: www.dcat.orgDownload Document from Source WebsiteFile Size: 310,19 KBShare Document on Facebook |
Biotechnology, BS "DBEFNJD.BQ 5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBTDocID: 1xTqy - View Document | |
PDF DocumentDocID: 1wroO - View Document | |
Building A Better Mousetrap: Patenting Biotechnology In The European CommunityDocID: 1vr7C - View Document | |
BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prodDocID: 1vq6b - View Document | |
Biotechnology Consultation Agency Response Letter BNFDocID: 1vpUZ - View Document |